GE Aerospace reports news on its aircraft engine, services, and systems business, including commercial engine orders, long-term service support, maintenance, repair and overhaul investments, and digital tools used in production, supply chain, and military aircraft readiness. Coverage includes customer selections for GEnx and other GE Aerospace or CFM-powered fleets, dividend declarations, workforce-training initiatives, and governance matters involving defense-related products.
GE (NYSE:GE) has announced the pricing for its offers to purchase various debt securities totaling up to $2.7 billion and $3.9 billion from GE Capital and GE Company, respectively. The Tender Offers include the Any and All Notes, Capital Notes, and Company Notes, with participation cut-off dates set. Over the early participation period, the maximum amounts for both GE Capital and GE Company Notes were reached, leading to no further tenders being accepted. The early payment date is expected around June 9, 2021, and the expiration date for these offers is set for June 21, 2021.
GE (NYSE:GE) has disclosed results for its recent debt securities tender offers, aimed at enhancing liquidity and managing capital structure. The offers include up to $2.73 billion of GE Capital Notes and up to $3.91 billion of GE Company Notes. Notably, cumulative tenders exceeded amounts offered, leading to a proration factor of about 86.6% for certain GE Capital Notes. The Early Participation Date was June 7, 2021, with the Early Payment Date expected on June 9, 2021. The expiration for the offers is set for June 21, 2021.
GE Healthcare is partnering with the American College of Cardiology (ACC) to advance digital health innovation in cardiology. This collaboration aims to leverage AI and digital technology to enhance patient care pathways for conditions like atrial fibrillation and coronary artery disease. The ACC's Consortium will unite diverse stakeholders to build a roadmap for AI integration in healthcare, with GE contributing its Edison platform, which serves as a foundation for AI applications in cardiovascular care.
GE (NYSE:GE) has announced its tender offers to purchase debt securities, including the 'Any and All Notes' and 'Capital Notes' with a maximum aggregate purchase price of up to $1,000,000,000 each. The offers aim to reduce leverage in line with GE's strategic objectives. Key deadlines include the Early Participation Date on June 7, 2021, and the Expiration Date on June 21, 2021. Accepted notes will be retired, reducing GE's outstanding obligations and potentially strengthening its financial position.
GE (NYSE:GE) has announced multiple cash offers to purchase its debt securities, including the Any and All Tender Offer for $2.865 billion, Capital Notes Tender Offer and Company Notes Tender Offer, each capped at $1 billion. These offers aim to reduce leverage by retiring outstanding debt. The tender offers commence on May 24, 2021, with various critical dates including early participation and expiration dates. The Total Consideration will vary for each series of notes and will include accrued interest. GE reserves the right to amend or terminate the offers at its discretion.
GE Digital has been recognized in the top four for critical capabilities in the 2021 Gartner Critical Capabilities for Manufacturing Execution Systems report. The company’s flagship software, Proficy Plant Applications, enhances operations management across various manufacturing sectors. Developed over 25 years, it integrates data management and production processes to optimize performance and reduce costs. This recognition underscores GE Digital's commitment to providing innovative industrial software that meets diverse manufacturing needs.
Current Lighting Solutions and GE have signed a collaboration agreement focused on Potassium Fluorosilicate (PFS/KSF) phosphor for MiniLED and MicroLED applications. This partnership aims to enhance next-generation display technologies, building on their established relationship in phosphor development. Bill Cohen from Current emphasizes the innovation potential, while Patrick Patnode from GE highlights customer benefits. Both companies will leverage each other's expertise to bring phosphor innovations to market effectively.
GE Healthcare has announced the acquisition of Zionexa, a company specializing in in-vivo oncology and neurology biomarkers, aiming to enhance personalized healthcare. The acquisition focuses on the development of Zionexa’s pipeline biomarkers and the FDA-approved PET imaging agent, Cerianna, which aids in detecting estrogen receptor-positive lesions in patients with metastatic breast cancer. GE plans to expand Cerianna's accessibility from 25% to at least 75% of the patient population by 2023. Financial details of the acquisition remain undisclosed.
RWE Renewables has partnered with GE Renewable Energy to repower the Panther Creek III wind farm in West Texas, enhancing the efficiency of 133 turbines. This project began production in 2009 and is expected to be complete by Q3 2021. The upgrades include the installation of longer blades and new gearboxes, which will increase the farm's annual output from its 215 MW capacity. Additionally, used turbine blades will be recycled, contributing to a sustainable circular economy.
GE Renewable Energy’s Grid Solutions (NYSE: GE) and Hitachi ABB Power Grids have announced a non-exclusive cross-licensing agreement to utilize a fluoronitrile-based gas mixture as an alternative to sulfur hexafluoride (SF6). This eco-efficient solution notably reduces environmental impact and aims to standardize SF6-free technology in high voltage equipment. The agreement highlights the growing commitment of both companies to aiding utilities in decreasing greenhouse gas emissions, with GE’s g3 gas showing over 99% lower global warming potential compared to SF6.